z-logo
Premium
Prevalence and clinical correlates of flunitrazepam‐related complex sleep behaviors
Author(s) -
Tsai JuiKang,
Yen ChiaNan,
Chen ChengSheng,
Hwang TzungJeng,
Chen ShaoTsu,
Chen TzuTing,
Ko ChihHung,
Su PoWen,
Chang YuPing,
Lin JinJia,
Yen ChengFang
Publication year - 2017
Publication title -
psychiatry and clinical neurosciences
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.609
H-Index - 74
eISSN - 1440-1819
pISSN - 1323-1316
DOI - 10.1111/pcn.12472
Subject(s) - flunitrazepam , logistic regression , odds ratio , confidence interval , medicine , alcohol use disorder , psychiatry , alcohol , benzodiazepine , biology , biochemistry , receptor
Aim Complex sleep behaviors ( CSB ) are often associated with the use of hypnotic drugs. This study investigated the prevalence and correlates of CSB among psychiatric patients who were given flunitrazepam. Methods From J une 2011 to M ay 2012, a total of 268 psychiatric outpatients who had received flunitrazepam for at least 3 months were enrolled. Data on occurrence of CSB , demographic characteristics, flunitrazepam dosage and duration of use, psychiatric diagnoses, physical illnesses, and alcohol use were collected. Logistic regression analysis was used to examine the clinical correlates of CSB . Results Sixty‐six participants (24.6%) reported experiencing CSB . Logistic regression analysis showed that a high dosage (>2 mg/day) of flunitrazepam (odds ratio [ OR ] = 1.941, 95% confidence interval [ CI ] = 1.090–3.455, P  = 0.024) and alcohol use ( OR  = 1.948, 95%CI = 1.023–3.709, P  = 0.042) were significantly associated with the occurrence of CSB . Sex, age, duration of flunitrazepam use, psychiatric diagnoses, and physical illnesses were not significantly associated with the occurrence of CSB . Conclusion CSB among flunitrazepam users should be monitored routinely, especially among those receiving a high dosage who also consume alcohol.

This content is not available in your region!

Continue researching here.

Having issues? You can contact us here
Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom